| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 82728 |
|
341 |
338 |
$0.00 |
| 87340 |
|
117 |
116 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
769 |
570 |
$0.00 |
| 3052F |
|
40 |
40 |
$0.00 |
| 86141 |
|
332 |
322 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
293 |
289 |
$0.00 |
| 3079F |
|
266 |
262 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
766 |
718 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
208 |
207 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
262 |
260 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
878 |
870 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,914 |
3,416 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
14 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,126 |
1,109 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,315 |
2,874 |
$0.00 |
| 82043 |
|
578 |
573 |
$0.00 |
| 74174 |
|
194 |
194 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
76 |
73 |
$0.00 |
| 3044F |
|
700 |
692 |
$0.00 |
| 85652 |
|
321 |
312 |
$0.00 |
| 83735 |
|
271 |
247 |
$0.00 |
| 3075F |
|
339 |
329 |
$0.00 |
| 90656 |
|
171 |
171 |
$0.00 |
| 90677 |
|
90 |
90 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
360 |
357 |
$0.00 |
| 81001 |
|
474 |
451 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
104 |
97 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
6,246 |
5,213 |
$0.00 |
| 86901 |
|
25 |
25 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,338 |
2,298 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
25 |
25 |
$0.00 |
| 96415 |
|
118 |
96 |
$0.00 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$0.00 |
| 85027 |
|
1,034 |
990 |
$0.00 |
| 3074F |
|
1,045 |
962 |
$0.00 |
| 83550 |
|
341 |
338 |
$0.00 |
| 86706 |
|
101 |
101 |
$0.00 |
| 86160 |
|
12 |
12 |
$0.00 |
| 85730 |
|
95 |
95 |
$0.00 |
| 90686 |
|
122 |
122 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
115 |
115 |
$0.00 |
| 82607 |
|
41 |
41 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
31 |
31 |
$0.00 |
| 86780 |
|
41 |
41 |
$0.00 |
| 1111F |
|
230 |
221 |
$0.00 |
| 3080F |
|
36 |
36 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 92227 |
|
41 |
41 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
14 |
$0.00 |
| 92250 |
|
27 |
27 |
$0.00 |
| 86850 |
|
13 |
13 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
357 |
328 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
491 |
345 |
$0.00 |
| 83540 |
|
350 |
347 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
159 |
155 |
$0.00 |
| 80061 |
Lipid panel |
1,597 |
1,587 |
$0.00 |
| 82540 |
|
578 |
573 |
$0.00 |
| 86705 |
|
81 |
81 |
$0.00 |
| 3077F |
|
288 |
273 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
127 |
127 |
$0.00 |
| 84100 |
|
314 |
301 |
$0.00 |
| 3046F |
|
155 |
152 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
422 |
260 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,399 |
2,379 |
$0.00 |
| 85610 |
|
840 |
718 |
$0.00 |
| 82274 |
|
620 |
619 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
14 |
14 |
$0.00 |
| 82570 |
|
183 |
170 |
$0.00 |
| 86703 |
|
329 |
327 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
15 |
15 |
$0.00 |
| 82565 |
|
39 |
39 |
$0.00 |
| 3078F |
|
1,330 |
1,220 |
$0.00 |
| 90715 |
|
27 |
27 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
141 |
110 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
31 |
31 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
63 |
63 |
$0.00 |
| 84439 |
|
262 |
255 |
$0.00 |
| 90750 |
|
81 |
81 |
$0.00 |
| 97161 |
|
27 |
27 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
93 |
93 |
$0.00 |
| 81003 |
|
44 |
43 |
$0.00 |
| 90661 |
|
25 |
25 |
$0.00 |
| 3051F |
|
154 |
151 |
$0.00 |
| 76642 |
|
96 |
91 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
91 |
88 |
$0.00 |
| 83970 |
|
52 |
51 |
$0.00 |
| 90653 |
|
36 |
36 |
$0.00 |
| 86900 |
|
25 |
25 |
$0.00 |
| 80076 |
|
30 |
30 |
$0.00 |
| 97803 |
|
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$0.00 |
| 86480 |
|
13 |
12 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$0.00 |
| 77062 |
|
119 |
119 |
$0.00 |
| 77080 |
|
12 |
12 |
$0.00 |
| 77066 |
Tomosynthesis, mammo |
14 |
14 |
$0.00 |